These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

696 related items for PubMed ID: 7540658

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N, Mendel I, Ben-Nun A.
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
    Tan LJ, Kennedy MK, Miller SD.
    J Immunol; 1992 May 01; 148(9):2748-55. PubMed ID: 1374098
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE.
    Vanderlugt CL, Karandikar NJ, Lenschow DJ, Dal Canto MC, Bluestone JA, Miller SD.
    J Neuroimmunol; 1997 Nov 01; 79(2):113-8. PubMed ID: 9394783
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination.
    Cross AH, Tuohy VK, Raine CS.
    Cell Immunol; 1993 Feb 01; 146(2):261-9. PubMed ID: 7513616
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response.
    Bischof F, Bins A, Dürr M, Zevering Y, Melms A, Kruisbeek AM.
    J Immunol; 2004 Jul 01; 173(1):600-6. PubMed ID: 15210822
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
    Theien BE, Vanderlugt CL, Nickerson-Nutter C, Cornebise M, Scott DM, Perper SJ, Whalley ET, Miller SD.
    Blood; 2003 Dec 15; 102(13):4464-71. PubMed ID: 12933585
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice.
    Tuohy VK, Sobel RA, Lu Z, Laursen RA, Lees MB.
    J Neuroimmunol; 1992 Jul 15; 39(1-2):67-74. PubMed ID: 1377711
    [Abstract] [Full Text] [Related]

  • 40. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis.
    Jones RE, Bourdette D, Moes N, Vandenbark A, Zamora A, Offner H.
    J Immunol; 2003 Feb 15; 170(4):1690-8. PubMed ID: 12574332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.